-
Pertuzumab Plus Trastuzumab with or Without Chemotherapy Followed by Emtansine in ERBB2 -Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Huober, J., Weder, P., Ribi, K., Thürlimann, B., Thery, J-C., Li, Q., Vanlemmens, L., Guiu, S. V., Brain, E., Grenier, J., Dalenc, F., Levy, C., Savoye, A-M., Müller, A., Membrez-Antonioli, V. R., Gérard, M-A., Lemonnier, J. R., Hawle, H., Dietrich, D., Boven, E., & 1 others , 19 Oct 2023, In: JAMA Oncology. 9, 10, p. 1381-1389 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
Bos, M. K., Lam, S. W., Motta, G., Helmijr, J. C. A., Beaufort, C. M., de Jonge, E., Martens, J. W. M., Boven, E., Jansen, M. P. H. M., Jager, A. & Sleijfer, S., Jul 2023, In: Breast cancer research and treatment. 200, 2, p. 271-279 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib
Diekstra, M. H. M., Swen, J. J., van der Zanden, L. F. M., Vermeulen, S. H., Boven, E., Mathijssen, R. H. J., Fukunaga, K., Mushiroda, T., Hongo, F., Oosterwijk, E., Cambon-Thomsen, A., Castellano, D., Fritsch, A., Donas, J. G., Rodriguez-Antona, C., Ruijtenbeek, R., Radu, M. T., Eisen, T., Junker, K., Roessler, M., & 6 others , 1 Jun 2022, In: Cancers. 14, 12, 2838.Research output: Contribution to journal › Article › Academic › peer-review
- All publications